Korean Drug Co Ltd
KOSDAQ:014570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Korean Drug Co Ltd
KOSDAQ:014570
|
KR |
|
MCH Group AG
SIX:MCHN
|
CH |
|
F
|
Filinvest Development Corp
XPHS:FDC
|
PH |
|
Anglo Pacific Group PLC
LSE:APF
|
UK |
|
A
|
Anima Holding SpA
F:124
|
IT |
|
Melia Hotels International SA
MAD:MEL
|
ES |
|
LM Funding America Inc
NASDAQ:LMFA
|
US |
|
Rupert Resources Ltd
XTSX:RUP
|
CA |
|
Capstone Companies Inc
OTC:CAPC
|
US |
|
KMD Brands Ltd
NZX:KMD
|
NZ |
|
M
|
Mida Assets PCL
SET:MIDA
|
TH |
|
E
|
Eventbrite Inc
F:EB4
|
US |
|
B
|
Bangkok Ranch PCL
SET:BR
|
TH |
|
Arcelormittal South Africa Ltd
F:ISC1
|
ZA |
|
American Electric Power Company Inc
NASDAQ:AEP
|
US |
|
A
|
Arcelormittal South Africa Ltd
XMUN:ISC1
|
ZA |
|
Max Resource Corp
XTSX:MAX
|
CA |
|
N
|
Nam Cheong Ltd
SGX:N4E
|
SG |
Dividends
Dividend Yield
Korean Drug Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Korean Drug Co Ltd
Payout Ratio
Korean Drug Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Korean Drug Co Ltd is hidden .
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Korean Drug Co Ltd
| Average Annual Return | -16.12% |
| Standard Deviation of Annual Returns | 14.08% |
| Max Drawdown | -68% |
| Market Capitalization | 38.1B KRW |
| Shares Outstanding | 11 000 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Korean Drug Co Ltd's latest stock split occurred on Apr 17, 2006
The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.
The adjusted shares began trading on Apr 17, 2006. This was the only stock split in Korean Drug Co Ltd's history.
